Extracellular Matrix Mediates BMP-2 in a Model of Temporomandibular Joint Osteoarthritis
Overview
Cell Biology
Authors
Affiliations
Temporomandibular joint (TMJ) osteoarthritis (OA) is a complex disease that affects both cartilage and subchondral bone. It is accompanied by loss of extracellular matrix (ECM) and may be controlled by bone morphogenetic protein-2 (BMP-2). We analyzed the effect of BMP-2 in both cartilage and subchondral bone in a TMJ-OA animal model that is deficient in biglycan (Bgn) and fibromodulin (Fmod) (Bgn-/-Fmod-/-). Whole mandibles were dissected from 3-week-old wild-type (WT) and Bgn-/-Fmod-/- mice and incubated with and without 250 µg/mL BMP-2 for 2 days using an explant culture system. Condyle growth was measured by microCT and the expression levels of cartilage and bone-related genes were analyzed using RT-PCR or by immunohistochemistry from condyles that contained an intact cartilage/subchondral bone interface. Osteoclast activity was estimated by tartrate-resistant acid phosphatase (TRAP) staining and by TRAP, Rankl, and Adamts4 mRNA expression levels. Our results showed that most parameters examined were slightly up-regulated in WT samples treated with BMP-2, and this up-regulation was significantly enhanced in the Bgn-/-Fmod-/- mice. The up-regulation of both catabolic and anabolic agents did not appear to positively affect the overall growth of Bgn-/-Fmod-/- condyles compared to WT controls. In summary, the up-regulation of both anabolic and catabolic genes in the WT and Bgn-/-Fmod-/- TMJs treated with BMP-2 suggests that BMP increases matrix turnover in the condyle, and, further, that Bgn and Fmod could have protective roles in regulating this process.
Uptegrove A, Chen C, Sahagun-Bisson M, Kulkarni A, Louie K, Ueharu H Arch Oral Biol. 2024; 169:106096.
PMID: 39341045 PMC: 11609011. DOI: 10.1016/j.archoralbio.2024.106096.
Long-term haplodeficency of DSPP causes temporomandibular joint osteoarthritis in mice.
Liu Q, Zhao Y, Shi H, Xiang D, Wu C, Song L BMC Oral Health. 2024; 24(1):569.
PMID: 38745274 PMC: 11094853. DOI: 10.1186/s12903-024-04320-8.
Osteoarthritis of the Temporomandibular Joint: A Narrative Overview.
Melou C, Pellen-Mussi P, Jeanne S, Novella A, Tricot-Doleux S, Chauvel-Lebret D Medicina (Kaunas). 2023; 59(1).
PMID: 36676632 PMC: 9866170. DOI: 10.3390/medicina59010008.
A novel approach to establishing a temporomandibular joint fibrocartilage cell line.
Qiao Y, Yi D, Reed D, Mercuri L, Chen D, Oh C J Dent Sci. 2022; 17(3):1378-1386.
PMID: 35784155 PMC: 9236962. DOI: 10.1016/j.jds.2022.04.017.
Molecular signaling in temporomandibular joint osteoarthritis.
Lu K, Ma F, Yi D, Yu H, Tong L, Chen D J Orthop Translat. 2022; 32:21-27.
PMID: 35591935 PMC: 9072795. DOI: 10.1016/j.jot.2021.07.001.